IKZF1 and acute myeloid leukemia: According to the available drug response data, combination therapy of demethylation agents and Homoharringtonine (HHT)/all‐trans‐retinoic acid (ATRA) showed potential sensitivity in IKZF1 N159S‐positive AML (Table S1).